InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by VANCE DOLLY, Directeur Exécutif. Director active across 1 companies, notably RIGEL PHARMACEUTICALS INC. Aggregated, 2 filings have been logged. The latest transaction was filed on 24 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
050,000 shares0
Common Stock
SEC:0001567619-22-001778·
050,000 shares0
Common Stock
SEC:0001567619-22-001778:0·
2 of 2 declarations
About VANCE DOLLY
VANCE DOLLY is the Executive Vice President of Corporate Affairs, General Counsel, and Secretary at RIGEL PHARMACEUTICALS INC. She oversees the company's legal affairs and regulatory compliance. Her role is essential in ensuring that the organization adheres to laws while pursuing its business objectives.
